attention deficit hyperactivity disorder
Conditions
Interventions
1:Oral methylphenidate hydrochloride tablets
Sponsors
Deyang people's Hospital
Eligibility
Sex/Gender
All
Age
6 Years to 17 Years
Inclusion criteria
Inclusion criteria: 1. It meets the diagnostic criteria for ADHD in DSM-IV and is confirmed by the kiddie sads lifelong version of the school-age children's affective disorder and schizophrenia questionnaire; 2. Age: 6-17 years old (based on the date of signing the informed consent), gender: unlimited, no intellectual abnormality based on clinical judgment; 3. No drug treatment for ADHD was received 1 week before screening; 4. Patients and legal guardians understand and are willing to participate in the trial and sign the informed consent (patients under 8 years old may not sign the informed consent, but their consent is required).
Exclusion criteria
Exclusion criteria: 1. the weight is less than 18kg or more than 75kg; 2. Pregnant or lactating female subjects; 3. Patients or parents / caregivers can't understand the Chinese guidance, can't communicate fully, and can't complete the evaluation of the test scale; 4. Subjects with neurological diseases or other serious somatic diseases; 5. Have a history of severe brain trauma leading to coma; 6. Subjects at risk of suicide or impulsive aggression; 7. The patient has a history of alcohol or drug abuse (judged by the investigator as excessive or forced use) in the past 3 months, or is currently using alcohol, drugs or any prescription or over-the-counter drugs and is regarded as a subject in the abuse category by the investigator; 8. Previous systemic treatment was ineffective, severe allergy to methylphenidate and similar drugs, and multiple adverse drug reactions; 9. Participated in other clinical studies or participated in other clinical studies at the same time 2 weeks before screening; 10. For other reasons, the researcher considered that the patient was not suitable to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SNAP-IV scale;Blood concentration of methylphenidate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Iowa Conners scale;Weiss Functional Impairment Rating Scales;clinical global impression scale; | — |
Countries
China
Contacts
Public ContactLi Mupeng
Deyang people's Hospital
Outcome results
None listed